KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,170,000 | +9.3% | 91,435 | +3.4% | 0.12% | +41.9% |
| Q3 2014 | $2,899,000 | -13.4% | 88,470 | +1.4% | 0.09% | -22.5% |
| Q2 2014 | $3,346,000 | -2.1% | 87,208 | +1.4% | 0.11% | +24.7% |
| Q1 2014 | $3,419,000 | +13.4% | 85,992 | +6.6% | 0.09% | -3.3% |
| Q4 2013 | $3,014,000 | -20.1% | 80,685 | -2.5% | 0.09% | -34.3% |
| Q3 2013 | $3,773,000 | +28.6% | 82,794 | -23.7% | 0.14% | +12.0% |
| Q2 2013 | $2,935,000 | – | 108,501 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |